Last updated: 2026-10-10 00:43:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Eli Lilly & Co. (LLY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $1,178.38, with a market capitalization of $1.06T and a P/E ratio of 39.03. Over the past 52 weeks, its price has ranged from $783.85 to $1,292.65. This page covers its latest market performance, valuation, price trends and company information.
$1.06T | |
$1,153.56 | |
$1,292.65 | |
$27.21 | |
$1,169.60 | |
1.12M | |
2.50M | |
39.03 | |
$1,292.65 | |
$783.85 | |
0.55% | |
-- |
Eli Lilly & Co. (LLY) last closed at $1,169.60 as of 2026-10-09 23:59:16, unchanged from the previous close of $1,169.60.
During the latest regular trading session, LLY traded between $27.21 and $1,292.65, with a volume of 1.12M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Eli Lilly & Co. (LLY) moved from $1,157.08 to $1,178.38, representing a gain of 1.84% ($21.30).
The stock traded between $1,131.21 and $1,215.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 2.45 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 77.5%
LLY is currently trading at $1,178.38, placing it 77.5% of the way from its 52-week low of $783.85 to its 52-week high of $1,292.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 50000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Eli Lilly & Co. (LLY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.